Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding trial of tolvaptan in peritoneal dialysis patients with chronic renal failure
jRCT2080222135Phase 2
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tolvaptan in chronic kidney disease (CKD) and hypervolemia, sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
tolvaptan
03
Conditions
chronic kidney disease (CKD)hypervolemia
Beyond the preview
Go deeper on jRCT2080222135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222135.